Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1475-2867

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors ; volume:18 ; number:1 ; day:24 ; month:4 ; year:2018 ; pages:1-12 ; date:12.2018
Cancer cell international ; 18, Heft 1 (24.4.2018), 1-12, 12.2018

Creator: Aveic, Sanja

Contributor: Pantile, Marcella
Polo, Pierfrancesco
Sidarovich, Viktoryia
Mariano, Marilena De
Quattrone, Alessandro
Longo, Luca
Tonini, Gian Paolo
SpringerLink (Online service)

DOI: 10.1186/s12935-018-0557-4

URN: urn:nbn:de:101:1-2018062823181425450732

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Aveic, Sanja
Pantile, Marcella
Polo, Pierfrancesco
Sidarovich, Viktoryia
Mariano, Marilena De
Quattrone, Alessandro
Longo, Luca
Tonini, Gian Paolo
SpringerLink (Online service)

Other Objects (12)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity

A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor

Editorial: Targeting bruton tyrosine kinase

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Hochschulschrift

Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells

Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

Second-generation inhibitors of Bruton tyrosine kinase

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity

A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor

Editorial: Targeting bruton tyrosine kinase

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Hochschulschrift

Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells

Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

Second-generation inhibitors of Bruton tyrosine kinase

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity

A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor

Editorial: Targeting bruton tyrosine kinase

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Hochschulschrift

Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells

Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

Second-generation inhibitors of Bruton tyrosine kinase

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity

A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor

Editorial: Targeting bruton tyrosine kinase

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells

Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

Second-generation inhibitors of Bruton tyrosine kinase

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity

A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor

Editorial: Targeting bruton tyrosine kinase

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells

Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

Second-generation inhibitors of Bruton tyrosine kinase

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity

A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor

Editorial: Targeting bruton tyrosine kinase

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells

Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

Second-generation inhibitors of Bruton tyrosine kinase

Related objects

Reset password